IP Library Granted Patent US 8,906,151
Granted Patent B2
US 8,906,151 · App. 12/160,971 · Granted Dec 9, 2014

Calcium phosphate composition and process for producing the same

Inventors: Tadashi Hashimoto (Okayama, JP); Takahiro Sekiguchi (Okayama, JP); Koichi Okada (Kurashiki, JP)
Assignee: Kuraray Noritake Dental Inc.
A61L27/425A61K6/033A61L24/0063C04B28/344A61K6/0008A61K6/0067A61K6/0215A61K6/024A61K6/0245A61K6/025A61K6/0255A61K6/0643C04B2111/00836
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,906,151
App. No.
12/160,971
Granted
Dec 9, 2014
Kind
B2
Abstract

A calcium phosphate composition comprising tetracalcium phosphate particles (A), calcium hydrogen phosphate particles (B) and at least one kind of inorganic particles (C) selected from silica particles or titania particles, wherein the mixing ratio (A/B) of (A) to (B) is from 45/55 to 55/45 in molar ratio, the inorganic particles (C) have an average particle diameter of from 0.002 to 0.5 μm, and the inorganic particles (C) are contained in an amount of 0.1 to 20 parts by weight based on 100 parts by weight of (A) and (B) in total. Thereby provided is a calcium phosphate composition such that when it is used as a material for bone repair, a formed bone has high mechanical strength and a high bone replacement rate is achieved.

Claims (15)

1. A powdered calcium phosphate composition comprising:

tetracalcium phosphate particles (A),

calcium hydrogen phosphate particles (B), and

at least one kind of inorganic particles (C) selected from silica particles or titania particles,

wherein the mixing ratio (A/B) of (A) to (B) is from 45/55 to 55/45 in molar ratio, the inorganic particles (C) have an average particle diameter of from 0.002 to 0.021 μm, and the inorganic particles (C) are contained in an amount of 0.1 to 20 parts by weight based on 100 parts by weight of (A) and (B) in total.

2. The powdered calcium phosphate composition according to claim 1 , wherein the tetracalcium phosphate particles (A) have an average particle diameter of from 5 to 30 μm.

3. The powdered calcium phosphate composition according to claim 1 , wherein the calcium hydrogen phosphate particles (B) have an average particle diameter of from 0.1 to 5 μm.

4. A method for producing a calcium phosphate composition paste comprising tetracalcium phosphate particles (A), calcium hydrogen phosphate particles (B) and at least one kind of inorganic particles (C) selected from silica particles or titania particles, the method comprising:

adding an aqueous solution or a buffered aqueous solution to a powder of a calcium phosphate composition in which the mixing ratio (A/B) of (A) to (B) is from 45/55 to 55/45 in molar ratio, the inorganic particles (C) have an average particle diameter of from 0.002 to 0.021 μm, and the inorganic particles (C) are contained in an amount of 0.1 to 20 parts by weight based on 100 parts by weight of (A) and (B) in total; and

kneading the resulting mixture.

5. A composition suitable for medical use comprising the powdered calcium phosphate composition according to claim 1 ; and at least one pharmacologically acceptable agent.

6. A bone cement comprising the powdered calcium phosphate composition according to claim 1 .

7. A composition suitable for medical use comprising the powdered calcium phosphate composition according to claim 2 ; and at least one pharmacologically acceptable agent.

8. A bone cement comprising the powdered calcium phosphate composition according to claim 2 .

9. A composition suitable for medical use comprising the powdered calcium phosphate composition according to claim 3 ; and at least one pharmacologically acceptable agent.

Assignments (2)
CHANGE OF NAME Recorded Aug 20, 2012
From: KURARAY MEDICAL INC.
To: KURARAY NORITAKE DENTAL INC.
Reel/Frame 028813/0704 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 23, 2008
From: HASHIMOTO, TADASHI; SEKIGUCHI, TAKAHIRO; OKADA, KOICHI
To: KURARAY MEDICAL INC.
Reel/Frame 021278/0051 →
Priority Claims (1)
JP 2006-008078 · Jan 16, 2006 · national
Continuity (1)
Related Publication 20100236449A1 · Sep 23, 2010